Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBerkeley Group Regulatory News (BKG)

Share Price Information for Berkeley Group (BKG)

Share Price is delayed by 15 minutes
Get Live Data
3,490.00    10.00 (0.29%)
Bid:
3,480.00
Ask:
3,484.00
Spread: 4.00 (0.115%)
Market Cap: £3.23b
BKG Live PriceLast checked at - London Stock Exchange

Intraday Berkeley Group Share Chart

Trading Statement

4 Sep 2020 07:00

RNS Number : 9888X
Berkeley Group Holdings (The) PLC
04 September 2020
 

 

The Berkeley Group Holdings plc

Trading Update

Period from 1 May 2020 to 31 August 2020

4 September 2020

 

The Berkeley Group Holdings plc ("Berkeley" or the "Company") is holding its Annual General Meeting today (which will be a closed meeting in accordance with recent Government legislation and related restrictions in response to COVID-19, and to minimise public health risks), at which it will provide the following Trading Update covering the period from 1 May 2020 to 31 August 2020.

 

Berkeley is the country's leading place-maker, operating principally in London, Birmingham and the South of England. We create beautiful, successful places where communities thrive and where people of all ages and backgrounds enjoy a great quality of life. This is the first trading update since the tragic and untimely passing of Berkeley's founder and previous Chairman, Tony Pidgley, CBE. Berkeley's strategy remains unchanged as does its clear purpose to build quality homes, strengthen communities and improve people's lives.

 

The start of this new financial year coincided with the evolving COVID-19 pandemic and the nationwide lockdown measures introduced to manage its impact upon the whole country. This has set unprecedented challenges for businesses to manage. First among these is the health, safety and well-being of all our stakeholders, followed by the detailed preparation and implementation of plans to return business operations to the optimum achievable levels of productivity, efficiency, collaboration and creativity.

 

We remain very mindful of the current volatility and the risks this presents to the UK and global economies as they come to terms with the longer term impact of COVID-19, including once current Government support tapers and in the event of a severe second wave of the virus. We are also conscious of the risks around the UK's departure from the European Union at the end of 2020.

 

Berkeley's trading has been resilient over this period and supports our existing guidance of £500 million of pre-tax profit for the full year and our commitment to our shareholder returns programme of £280 million per annum.

 

We now anticipate a more even split of profit between the first and second halves of the year, reflecting levels of production that have been better than initially anticipated and our decision not to furlough staff. Production continues to be impacted by the need for modified working practices and increased supervision, with the health, safety and well-being of our people remaining uppermost in our minds at all times. However, the experience and expertise of our construction teams and subcontractors, supported by our Health and Safety professionals, means that disruption has been minimised and efficiency levels are now at around 90% of normal.

 

In overall terms, this has been offset by the continued investment in bringing forward our portfolio of over 25 large regeneration developments accumulated over recent years. In the period, construction activity has started at a number of these, including Twelve Trees Park in East London and the site of the old Horlicks factory in Slough where we have consent for 3,800 and 1,300 homes, respectively. We are also progressing a number of new land opportunities on which we anticipate being in a position to update at the half year.

 

Sales pricing has been robust in the period and above our business plan levels. This has been supported by the demand for Berkeley properties in under-supplied markets, good mortgage availability and the welcome support from Government for the sector, including the temporary removal of SDLT for the first £500,000 of sales value and the announcement of a brief extension to the current Help to Buy scheme.

 

The value of underlying sales reservations for the first four months of the year is around 20% below the annualised run rate for last year, which is supportive of forward sales remaining around the year-end position of above £1.8 billion. This is a strong position, providing good visibility over the next two years of earnings.

 

Reflecting the ongoing investment in our sites, Berkeley currently has net cash in excess of £1 billion, ahead of next week's dividend payment.

 

As announced on 13 August 2020, a dividend of £134.3 million, or 107.0 pence per share, will be paid to shareholders on 11 September 2020 with the remainder of the £140.1 million return for the six months ending 30 September 2020 having already been satisfied through share buy-backs. The Company also announced that the next £140.1 million shareholder return will be provided by 31 March 2021 through a combination of dividends and share buy-backs. The amount to be paid as a dividend will be announced prior to the end of February 2021, taking account of any share buy-backs made in the intervening period.

 

END

For further information please contact:

The Berkeley Group Holdings plc Novella Communications

R J Stearn Tim Robertson

T: 01932 868 555 T: 020 3151 7008

 

LEI: 2138009OQSSLVVHQAL78

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSVASIVIII
Date   Source Headline
17th Sep 20205:40 pmRNSTransaction in Own Shares
14th Sep 20205:30 pmRNSTransaction in Own Shares
10th Sep 20208:30 amRNSDirector/PDMR Shareholding
8th Sep 20206:10 pmRNSTransaction in Own Shares
4th Sep 202012:15 pmRNSResult of AGM
4th Sep 20207:00 amRNSTrading Statement
1st Sep 20209:00 amRNSTotal Voting Rights
25th Aug 20209:30 amRNSDirector/PDMR Shareholding
13th Aug 20208:41 amRNSDividend Declaration
12th Aug 20207:00 amRNSHolding(s) in Company
10th Aug 20207:00 amRNSHolding(s) in Company
3rd Aug 20203:50 pmRNSNotice of AGM and Annual Report
3rd Aug 20209:00 amRNSTotal Voting Rights
30th Jul 20207:00 amRNSHolding(s) in Company
28th Jul 20201:36 pmRNSHolding(s) in Company
27th Jul 20208:00 amRNSHolding(s) in Company
23rd Jul 20207:00 amRNSHolding(s) in Company
23rd Jul 20207:00 amRNSDirectorate Change
1st Jul 20209:30 amRNSTotal Voting Rights
26th Jun 20203:55 pmRNSDirectorate Change
17th Jun 20207:00 amRNSFinal Results
1st Jun 20203:15 pmRNSTotal Voting Rights
1st May 20207:00 amRNSTotal Voting Rights
29th Apr 20209:00 amRNSArticles of Association
14th Apr 20205:40 pmRNSDirector/PDMR Shareholding
1st Apr 20207:00 amRNSTotal Voting Rights
27th Mar 20209:20 amRNSCOVID-19 Trading Update
18th Mar 20206:10 pmRNSTransaction in Own Shares
16th Mar 20206:00 pmRNSTransaction in Own Shares
12th Mar 20206:16 pmRNSDirector/PDMR Shareholding
12th Mar 20206:06 pmRNSDirector/PDMR Shareholding
12th Mar 20206:05 pmRNSDirector/PDMR Shareholding
12th Mar 20204:20 pmRNSDirector/PDMR Shareholding
12th Mar 20207:00 amRNSTrading Statement
4th Mar 202011:15 amRNSDirector/PDMR Shareholding
2nd Mar 202011:00 amRNSTotal Voting Rights
24th Feb 20207:00 amRNSProposed Capital Return: Publication of Circular
5th Feb 20204:50 pmRNSDirector/PDMR Shareholding
3rd Feb 202010:00 amRNSTotal Voting Rights
22nd Jan 20207:00 amRNSProposed Capital Return
2nd Jan 202011:00 amRNSTotal Voting Rights
17th Dec 201912:45 pmRNSDirector/PDMR Shareholding
6th Dec 20197:00 amRNSHalf-year Report
2nd Dec 201912:45 pmRNSTotal Voting Rights
1st Nov 201911:15 amRNSTotal Voting Rights
16th Oct 201911:25 amRNSDirector/PDMR Shareholding
16th Oct 201911:20 amRNSDirector/PDMR Shareholding
1st Oct 201910:10 amRNSTotal Voting Rights
30th Sep 20195:30 pmRNSDirector/PDMR Shareholding
25th Sep 20193:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.